Iridex (IRIX) Net Cash Flow Growth (3y) (2014 - 2026)
Iridex (IRIX) Net Cash Flow Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 157.80 Bn | 151.14 Bn | 6.27 Bn | -32.51% |
| 2 | Stryker | 115.54 Bn | 112.66 Bn | 3.81 Bn | -87.87% |
| 3 | Medtronic | 103.44 Bn | 95.27 Bn | 5.76 Bn | 42.74% |
| 4 | Boston Scientific | 72.38 Bn | 71.17 Bn | 3.61 Bn | -11.49% |
| 5 | Edwards Lifesciences | 49.76 Bn | 46.09 Bn | 1.29 Bn | -87.88% |
| 6 | Dexcom | 29.53 Bn | 28.42 Bn | 750.30 Mn | 129.29% |
| 7 | GE HealthCare Technologies | 29.51 Bn | 27.44 Bn | 1.98 Bn | -65.12% |
| 8 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -48.90% |
| 9 | Steris | 20.69 Bn | 20.27 Bn | 697.10 Mn | 33.47% |
| 10 | Iridex | 19.30 Mn | 14.71 Mn | 4.74 Mn | 20.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 20.40% |
| Jan 3, 2026 | 31.47% |
| Sep 27, 2025 | 18.04% |
| Jun 28, 2025 | 46.33% |
| Mar 29, 2025 | 51.69% |
| Dec 28, 2024 | -28.36% |
| Mar 30, 2024 | -28.08% |
| Sep 30, 2023 | -91.01% |
| Jul 1, 2023 | -64.48% |
| Apr 1, 2023 | -23.22% |
| Dec 31, 2022 | -86.00% |
| Oct 1, 2022 | 7.28% |
| Jul 2, 2022 | -21.77% |
| Apr 2, 2022 | 6.88% |
| Jan 1, 2022 | 94.89% |
| Apr 3, 2021 | 92.04% |
| Sep 26, 2020 | 30.18% |
| Jun 27, 2020 | -12.21% |
| Mar 28, 2020 | -150.51% |
| Dec 28, 2019 | -26.38% |